Presentation and validation of the multiple sclerosis depression rating scale: A test specifically devised to investigate affective disorders in multiple sclerosis patients

Accurate diagnosis of depression in patients affected by MS is important, as it may be a cause of reduced quality of life and increased suicide risk. We present a new scale, the Multiple Sclerosis Depression Rating Scale (MSDRS), and assess its diagnostic accuracy in comparison to the Beck Depression Inventory (BDI). A total of 94 MS participants were classified as non-depressed (N=44) or affected by mood disorder associated to MS with depressive manifestations (MSD-MDDM; N=37) or with a major depression-like episode (MSD-MDL; N=13). Each participant underwent a psychiatric interview, MSDRS, and BDI; diagnostic accuracy was evaluated using area under the ROC curve (AROC). The diagnostic accuracy of MSDRS and BDI was comparable when diagnosing both MSD-MDDM and MSD-MDL (AROC respectively 0.8998 and 0.8659); the MSDRS showed higher accuracy for the diagnosis of MSD-MDL (AROC respectively 0.9278 and 0.8314; p=.038). The MSDRS may be a reliable tool for the diagnosis of depression in MS.